Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CYIOS Corporation is a public holding company that operates within the health, wellness, and biotechnology sectors. The company primarily focuses on the development and distribution of hemp-based CBD products through its subsidiary, Choice Wellness, and its brand, Helio. CYIOS integrates health-tech solutions, including telehealth and blockchain-based supply chain tracking, to support its product ecosystem. Its business model is centered on the acquisition and growth of brands targeting the natural medicine and lifestyle wellness markets. The company aims to provide high-quality, lab-tested products to consumers seeking alternative treatments for pain and anxiety. By leveraging digital platforms, CYIOS seeks to streamline the patient-to-provider experience in the wellness space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CYIOS.